Developer docs
API playgroundTry for free, no card

Search company profiles

Bimeda

Full company profile

uuid000agcn

Namestring
Bimeda
Legal namestring
Bimeda Inc.
Websiteurl
bimedaus.com
Company typeenum
Private
Founded yearint
1960
Descriptiontext

Bimeda is a privately held global animal health company founded in Ireland in 1960 that manufactures, markets, and distributes veterinary pharmaceuticals and animal health products. The company operates 9 manufacturing facilities across 7 countries (including Ireland, the U.S., the U.K., Canada, Brazil, Argentina, China, and France), employs 1,200+ people globally, and reaches more than 80 countries across six continents through a network of authorized distributors, retail partners, and veterinary clinics. Its headquarters are in Dublin, Ireland, with the U.S. headquarters in Schaumburg, Illinois.

The core product portfolio is organized across five categories — ecto- and endo-parasiticides (Bimectin, Eprimectin, Doracide, MoxiSolv), water soluble antimicrobials (EnroMed, SpectoGard), injectables (BiloVet, Gamrozyne, BOVitalize Plus), nutritional products, and vaccines (Bimeda Biologicals) — serving three primary segments: livestock producers (cattle, swine, poultry), equine veterinarians and horse owners, and companion animal veterinarians. Bimeda's technology positioning centers on FDA-approved bioequivalent (ANADA) products that deliver clinically equivalent efficacy to pioneer-brand animal health products at competitive prices, supported by 8 R&D and 7 regulatory laboratories across four continents and proprietary formulations such as soluble glass trace element boluses (Cosecure Cattle) and Aspergillus oryzae-enhanced cattle supplements.

Bimeda generates revenue through one-time product sales via channel partners, including authorized animal health distributors, mass-market retail (Amazon, Chewy, Tractor Supply), and equine specialists (SmartPak, Dover Saddlery), with prescription products sold through veterinary clinics. The company is privately held with no disclosed parent, PE sponsor, or institutional investors, and has grown through a combination of organic product launches and strategic acquisitions over its 65-year history. Recent strategic activity is concentrated in the U.S. market, where Bimeda has launched or expanded at least six products or SKUs between November 2025 and May 2026 and added senior commercial leadership.

Short descriptiontext

Bimeda is a privately held, Ireland-founded global animal health company that manufactures and distributes FDA-approved bioequivalent veterinary pharmaceuticals — parasiticides, antimicrobials, injectables, vaccines, and nutritionals — across 80+ countries, serving livestock producers, equine veterinarians, and companion animal practitioners through distributors and retail partners.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLe Sueur, United States
HQ citystring
Le Sueur
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices12 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary pharmaceuticals, animal health products, livestock parasiticides, equine pharmaceuticals, veterinary vaccines
Industry5 codes
PRIMARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAB
Livestock & Production Animal Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAC
Equine Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAE
Antimicrobials & Anti-infectives
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMALAN
Species-Specific Supplements (Dog/Cat/Other Companion Species)
SIC code2 codes
  • Pharmaceutical Preparations2834
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Pharmaceuticals
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Animal health product sales
TypeOne Time License
Description

Sale of veterinary pharmaceuticals and animal health products including parasiticides, antimicrobials, injectables, and nutritional supplements to livestock producers, equine practitioners, and companion animal veterinarians through distributor and retail channels

bimedaus.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1Gastrobim™
Description

First and only FDA-approved bioequivalent to GastroGard® (omeprazole) for equine gastric ulcer treatment.

bimedaus.com
+6 more records
Core offering1 text field

Bimeda is a global manufacturer, marketer, and distributor of veterinary pharmaceuticals and animal health products. Its portfolio spans ecto- and endo-parasiticides, water soluble antimicrobials, injectables, nutritional products, vaccines, and trace element boluses serving livestock (cattle, swine, poultry), equine, and companion animal markets. Products are FDA-approved bioequivalents to pioneer brands, delivered through authorized distributors, veterinary clinics, and retail partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Gastrobim became fastest-growing omeprazole product in Canada and Europe since 2022/2024 launch
+1 more record
Product overview1 text field

Bimeda is a global animal health company offering a comprehensive portfolio of veterinary pharmaceuticals and animal health products organized across five key categories: ecto- and endo-parasiticides (Bimectin®, Eprimectin™, Doracide™, MoxiSolv™), water soluble antimicrobials (Tetroxy®, SpectoGard®, Lincomed®, EnroMed®), injectables (BiloVet®, Gamrozyne™, BOVitalize Plus™), and nutritional products. The product portfolio serves multiple animal species including horses (equine) with products like Gastrobim™ for gastric ulcers, Polyglycan® for joint support, and Bimectin® Paste for parasites; livestock (cattle and swine) with parasite control, antibiotics, and vaccines; poultry; and companion animals (dogs, cats). Bimeda also operates a custom vaccine manufacturing division (Bimeda Biologicals) and offers SecureCattle® for stress reduction in cattle. The company positions itself as a provider of both generic/bioequivalent products (approved under ANADA) and pioneer-quality formulations at competitive price points.

Product and service19 records
1Bimectin® Injection (ivermectin)
CategoryParasiticides
Description

Injectable parasiticide for cattle and swine providing effective treatment and control of a wide range of internal and external parasites including gastrointestinal roundworms, lungworms, grubs, sucking lice, and mange mites.

2Eprimectin™ Pour-On (eprinomectin)
CategoryParasiticides
Description

FDA-approved bioequivalent to Eprinex® pour-on for beef and dairy cattle including lactating dairy cattle. Provides broad-spectrum parasite control against 39 species and stages of internal and external parasites with zero milk and meat withdrawal time.

3BIMECTIN® Paste (ivermectin)
CategoryParasiticides
Description

Apple-flavored ivermectin paste anthelmintic and boticide for horses providing broadest spectrum activity against parasites and bots. Safe for horses of all ages including pregnant mares.

4BIMECTIN® Plus Injection
CategoryParasiticides
Description

Injectable parasiticide combining ivermectin and clorsulon for treatment and control of internal and external parasites including adult liver flukes in cattle.

5GASTROBIM™ (omeprazole)
CategoryEquine Pharmaceuticals
Description

First and only FDA-approved bioequivalent to GastroGard® for treatment and prevention of recurrence of gastric ulcers in horses and foals 4 weeks of age and older. Apple-flavored formulation.

6BOVitalize Plus™
CategoryNutritional Products
Description

Oral nutritional supplement for beef and dairy cattle containing trace minerals (Selenium, Copper, Zinc), vitamins (A, E), and Aspergillus oryzae for enhanced rumen efficiency and digestive support.

7SecureCattle®
CategoryAnimal Health Products
Description

Pour-on bovine appeasing substance (mBAS) solution designed to reduce the impact of stress on cattle and improve productivity. Available in 250mL (50-dose) and 1000mL (200-dose) sizes.

8MoxiSolv™ Injection
CategoryParasiticides
Description

FDA-approved bioequivalent to Cydectin® Injection containing 1% moxidectin for treatment and control of internal and external parasites in beef and non-lactating dairy cattle.

9Doracide™ (doramectin topical solution)
CategoryParasiticides
Description

Bioequivalent to Dectomax® Pour-On providing weatherproof parasite control for cattle. Controls 33 types of internal and external parasites with single dose including 77 days protection against biting cattle louse.

10EnroMed® 100 (enrofloxacin)
CategoryAntimicrobials
Description

FDA-approved bioequivalent to Baytril 100® sterile injectable fluoroquinolone for treatment and control of bovine respiratory disease (BRD) and swine respiratory disease (SRD).

11Gamrozyne™ (gamithromycin)
CategoryAntimicrobials
Description

First and only FDA-approved bioequivalent to Zactran® for treatment and control of Bovine Respiratory Disease (BRD). Reaches target tissue in 30 minutes with 10 days of treatment duration.

12BiloVet® (tylosin injection)
CategoryAntimicrobials
Description

Versatile, fast-acting antibiotic containing 200mg tylosin per mL for treatment of bovine respiratory complex, foot rot, calf diphtheria, metritis in cattle, and arthritis, pneumonia, erysipelas, dysentery in swine.

13SpectoGard® Sterile Solution (spectinomycin sulfate)
CategoryAntimicrobials
Description

First and only FDA-approved bioequivalent to Adspec® for treatment of bovine respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni.

14Cosecure Cattle (soluble glass trace element bolus)
CategoryNutritional Products
Description

World's only soluble glass trace element bolus manufactured at Bimeda's Denbigh, Wales facility. Provides controlled, constant rate delivery of trace elements for health and fertility of ruminants. UK and Ireland's only medicinal (POM-VPS, LM) multiple trace element bolus.

15Polyglycan® (hyaluronic acid + chondroitin sulfates + N-acetyl-D-glucosamine)
CategoryEquine Pharmaceuticals
Description

Joint support supplement for horses available in multiple formulations including Polyglycan®-SA, Polyglycan®-HV, and Polyglycan® Sterile Solution for IV/intra-articular use.

16Tandem™ Oral
CategoryEquine Pharmaceuticals
Description

Joint support supplement for horses containing hyaluronic acid, chondroitin sulfate, glucosamine and MSM in granule form for oral administration.

17Detomequin® (detomidine hydrochloride)
CategoryEquine Pharmaceuticals
Description

Sedative and analgesic for horses and yearlings to facilitate minor surgical and diagnostic procedures. Bioequivalent to Dormosedan® approved under ANADA #200-674.

18Custom Vaccines (autogenous vaccines)
CategoryVaccines
Description

Custom autogenous vaccine program through Bimeda Biologicals for customized vaccination solutions tailored to specific herd health challenges.

19Bimeda Biologicals (commercial cattle vaccines)
CategoryVaccines
Description

Commercial cattle vaccine portfolio including Myco-Bac® (killed Mycoplasma bovis vaccine), Pro-Bac™ Vaccines (killed bacterial vaccines), and Stimulator® Vaccines (modified live virus vaccines). Also includes custom vaccine manufacturing capabilities.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Generic Animal Drug Alliance (GADA)
Strategic tierCoreTypeOthers
Description

Bimeda is a proud member of GADA, an independent professional trade association representing the interests of generic animal drug companies. GADA supports education of veterinarians and the general public on generic drug safety, quality process, and FDA approval.

bimedaus.com
Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major animal health pharma player in livestock and companion animals. Overlaps with Bimeda in parasiticides, BRD therapeutics, and equine segments, competing for distributor and veterinarian mindshare.

TypeDirect peer
Description

Independent French-headquartered animal health company focused on livestock and companion animals. Comparable to Bimeda in size, geographic footprint, and portfolio composition across parasiticides and specialty therapeutics.

TypeDirect peer
Description

Independent global animal health company specializing in livestock and companion animal pharmaceuticals. Closely comparable to Bimeda in size, distribution model, and product breadth; both target veterinarians and livestock producers with parasiticides, anti-infectives, and specialty products.

TypeDirect peer
Description

Privately held UK/Irish-headquartered animal health manufacturer of generic veterinary pharmaceuticals. Closely comparable to Bimeda in manufacturing footprint, bioequivalent focus, and livestock/companion product mix.

TypeBroad incumbent
Description

Global animal health division of Merck/MSD, with deep livestock and companion animal portfolios. Competes with Bimeda across vaccines, anti-infectives, and parasiticides worldwide.

TypeDirect peer
Description

Privately held global animal health company with strong livestock, poultry, and companion portfolios. Highly comparable to Bimeda in scale, ownership structure (private), and focus on multi-species veterinary pharmaceuticals.

TypeDirect peer
Description

Global animal health and nutrition company serving livestock and companion markets. Comparable to Bimeda in targeting livestock producers with parasiticides, anti-infectives, and nutritional products.

TypeEmerging player
Description

Specialty animal health pharma company with strength in companion animal endocrinology, dermatology, and equine. Bimeda's equine portfolio (Gastrobim, Polyglycan) overlaps with Dechra's specialty veterinary segment.

TypeBroad incumbent
Description

Largest pure-play animal health company globally. Direct overlap with Bimeda across parasiticides, vaccines, anti-infectives, and equine products; Bimeda's bioequivalents target Zoetis's pioneer brands like GastroGard and Dectomax.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Top-three global animal health player with broad livestock, companion, and equine portfolios. Bimeda's Eprimectin (bioequivalent to Eprinex) and other parasiticide products directly compete with Boehringer's pioneer franchises.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries12 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bimeda

Veterinary Pharmaceuticalsbimedaus.com

Bimeda is a privately held, Ireland-founded global animal health company that manufactures and distributes FDA-approved bioequivalent veterinary pharmaceuticals — parasiticides, antimicrobials, injectables, vaccines, and nutritionals — across 80+ countries, serving livestock producers, equine veterinarians, and companion animal practitioners through distributors and retail partners.

What Bimeda does

Bimeda is a privately held global animal health company founded in Ireland in 1960 that manufactures, markets, and distributes veterinary pharmaceuticals and animal health products. The company operates 9 manufacturing facilities across 7 countries (including Ireland, the U.S., the U.K., Canada, Brazil, Argentina, China, and France), employs 1,200+ people globally, and reaches more than 80 countries across six continents through a network of authorized distributors, retail partners, and veterinary clinics. Its headquarters are in Dublin, Ireland, with the U.S. headquarters in Schaumburg, Illinois.

The core product portfolio is organized across five categories — ecto- and endo-parasiticides (Bimectin, Eprimectin, Doracide, MoxiSolv), water soluble antimicrobials (EnroMed, SpectoGard), injectables (BiloVet, Gamrozyne, BOVitalize Plus), nutritional products, and vaccines (Bimeda Biologicals) — serving three primary segments: livestock producers (cattle, swine, poultry), equine veterinarians and horse owners, and companion animal veterinarians. Bimeda's technology positioning centers on FDA-approved bioequivalent (ANADA) products that deliver clinically equivalent efficacy to pioneer-brand animal health products at competitive prices, supported by 8 R&D and 7 regulatory laboratories across four continents and proprietary formulations such as soluble glass trace element boluses (Cosecure Cattle) and Aspergillus oryzae-enhanced cattle supplements.

Bimeda generates revenue through one-time product sales via channel partners, including authorized animal health distributors, mass-market retail (Amazon, Chewy, Tractor Supply), and equine specialists (SmartPak, Dover Saddlery), with prescription products sold through veterinary clinics. The company is privately held with no disclosed parent, PE sponsor, or institutional investors, and has grown through a combination of organic product launches and strategic acquisitions over its 65-year history. Recent strategic activity is concentrated in the U.S. market, where Bimeda has launched or expanded at least six products or SKUs between November 2025 and May 2026 and added senior commercial leadership.

Bimeda firmographics

Firmographics
Name
Bimeda
Legal name
Bimeda Inc.
Website
https://bimedaus.com
Company type
Private
Founded year
1960
Operating status
Operating
Headcount range
51–100 employees
Short description
Bimeda is a privately held, Ireland-founded global animal health company that manufactures and distributes FDA-approved bioequivalent veterinary pharmaceuticals — parasiticides, antimicrobials, injectables, vaccines, and nutritionals — across 80+ countries, serving livestock producers, equine veterinarians, and companion animal practitioners through distributors and retail partners.
Ownership category
akta.pro rank

Bimeda industry classification

Industry
Product category
Veterinary Pharmaceuticals
SIC
Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAMAEAM
Generic & Private-Label Veterinary Pharmaceuticals
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAB
Livestock & Production Animal Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAC
Equine Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAE
Antimicrobials & Anti-infectives
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMALAN
Species-Specific Supplements (Dog/Cat/Other Companion Species)

Keywords

  • Veterinary pharmaceuticals
  • Animal health products
  • Livestock parasiticides
  • Equine pharmaceuticals
  • Veterinary vaccines

Where Bimeda is headquartered

Location

Headquarters

HQ city
Le Sueur
HQ country
United States
HQ region
North America

Offices12 records

Markets served

Bimeda business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Animal health product sales: Sale of veterinary pharmaceuticals and animal health products including parasiticides, antimicrobials, injectables, and nutritional supplements to livestock producers, equine practitioners, and companion animal veterinarians through distributor and retail channels

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Bimeda product offering

Product offering

Core offering

Bimeda is a global manufacturer, marketer, and distributor of veterinary pharmaceuticals and animal health products. Its portfolio spans ecto- and endo-parasiticides, water soluble antimicrobials, injectables, nutritional products, vaccines, and trace element boluses serving livestock (cattle, swine, poultry), equine, and companion animal markets. Products are FDA-approved bioequivalents to pioneer brands, delivered through authorized distributors, veterinary clinics, and retail partners.

Product overview

Bimeda is a global animal health company offering a comprehensive portfolio of veterinary pharmaceuticals and animal health products organized across five key categories: ecto- and endo-parasiticides (Bimectin®, Eprimectin™, Doracide™, MoxiSolv™), water soluble antimicrobials (Tetroxy®, SpectoGard®, Lincomed®, EnroMed®), injectables (BiloVet®, Gamrozyne™, BOVitalize Plus™), and nutritional products. The product portfolio serves multiple animal species including horses (equine) with products like Gastrobim™ for gastric ulcers, Polyglycan® for joint support, and Bimectin® Paste for parasites; livestock (cattle and swine) with parasite control, antibiotics, and vaccines; poultry; and companion animals (dogs, cats). Bimeda also operates a custom vaccine manufacturing division (Bimeda Biologicals) and offers SecureCattle® for stress reduction in cattle. The company positions itself as a provider of both generic/bioequivalent products (approved under ANADA) and pioneer-quality formulations at competitive price points.

Differentiator

Problem solved

Functional benefit

Brands

  • Gastrobim™: First and only FDA-approved bioequivalent to GastroGard® (omeprazole) for equine gastric ulcer treatment.
  • BOVitalize Plus™
  • Eprimectin™
  • SecureCattle®
  • Gamrozyne™
  • Doracide™
  • MoxiSolv™

Products and services

  • Bimectin® Injection (ivermectin) Injectable parasiticide for cattle and swine providing effective treatment and control of a wide range of internal and external parasites including gastrointestinal roundworms, lungworms, grubs, sucking lice, and mange mites.
  • Eprimectin™ Pour-On (eprinomectin) FDA-approved bioequivalent to Eprinex® pour-on for beef and dairy cattle including lactating dairy cattle. Provides broad-spectrum parasite control against 39 species and stages of internal and external parasites with zero milk and meat withdrawal time.
  • BIMECTIN® Paste (ivermectin) Apple-flavored ivermectin paste anthelmintic and boticide for horses providing broadest spectrum activity against parasites and bots. Safe for horses of all ages including pregnant mares.
  • BIMECTIN® Plus Injection Injectable parasiticide combining ivermectin and clorsulon for treatment and control of internal and external parasites including adult liver flukes in cattle.
  • GASTROBIM™ (omeprazole) First and only FDA-approved bioequivalent to GastroGard® for treatment and prevention of recurrence of gastric ulcers in horses and foals 4 weeks of age and older. Apple-flavored formulation.
  • BOVitalize Plus™ Oral nutritional supplement for beef and dairy cattle containing trace minerals (Selenium, Copper, Zinc), vitamins (A, E), and Aspergillus oryzae for enhanced rumen efficiency and digestive support.
  • SecureCattle® Pour-on bovine appeasing substance (mBAS) solution designed to reduce the impact of stress on cattle and improve productivity. Available in 250mL (50-dose) and 1000mL (200-dose) sizes.
  • MoxiSolv™ Injection FDA-approved bioequivalent to Cydectin® Injection containing 1% moxidectin for treatment and control of internal and external parasites in beef and non-lactating dairy cattle.
  • Doracide™ (doramectin topical solution) Bioequivalent to Dectomax® Pour-On providing weatherproof parasite control for cattle. Controls 33 types of internal and external parasites with single dose including 77 days protection against biting cattle louse.
  • EnroMed® 100 (enrofloxacin) FDA-approved bioequivalent to Baytril 100® sterile injectable fluoroquinolone for treatment and control of bovine respiratory disease (BRD) and swine respiratory disease (SRD).
  • Gamrozyne™ (gamithromycin) First and only FDA-approved bioequivalent to Zactran® for treatment and control of Bovine Respiratory Disease (BRD). Reaches target tissue in 30 minutes with 10 days of treatment duration.
  • BiloVet® (tylosin injection) Versatile, fast-acting antibiotic containing 200mg tylosin per mL for treatment of bovine respiratory complex, foot rot, calf diphtheria, metritis in cattle, and arthritis, pneumonia, erysipelas, dysentery in swine.
  • SpectoGard® Sterile Solution (spectinomycin sulfate) First and only FDA-approved bioequivalent to Adspec® for treatment of bovine respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somni.
  • Cosecure Cattle (soluble glass trace element bolus) World's only soluble glass trace element bolus manufactured at Bimeda's Denbigh, Wales facility. Provides controlled, constant rate delivery of trace elements for health and fertility of ruminants. UK and Ireland's only medicinal (POM-VPS, LM) multiple trace element bolus.
  • Polyglycan® (hyaluronic acid + chondroitin sulfates + N-acetyl-D-glucosamine) Joint support supplement for horses available in multiple formulations including Polyglycan®-SA, Polyglycan®-HV, and Polyglycan® Sterile Solution for IV/intra-articular use.
  • Tandem™ Oral Joint support supplement for horses containing hyaluronic acid, chondroitin sulfate, glucosamine and MSM in granule form for oral administration.
  • Detomequin® (detomidine hydrochloride) Sedative and analgesic for horses and yearlings to facilitate minor surgical and diagnostic procedures. Bioequivalent to Dormosedan® approved under ANADA #200-674.
  • Custom Vaccines (autogenous vaccines) Custom autogenous vaccine program through Bimeda Biologicals for customized vaccination solutions tailored to specific herd health challenges.
  • Bimeda Biologicals (commercial cattle vaccines) Commercial cattle vaccine portfolio including Myco-Bac® (killed Mycoplasma bovis vaccine), Pro-Bac™ Vaccines (killed bacterial vaccines), and Stimulator® Vaccines (modified live virus vaccines). Also includes custom vaccine manufacturing capabilities.

Quantifiable outcome

  • Gastrobim became fastest-growing omeprazole product in Canada and Europe since 2022/2024 launch
  • +1 more outcomes

Companies that use Bimeda

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Bimeda technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Bimeda partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Generic Animal Drug Alliance (GADA)coreOthersBimeda is a proud member of GADA, an independent professional trade association representing the interests of generic animal drug companies. GADA supports education of veterinarians and the general public on generic drug safety, quality process, and FDA approval.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Bimeda competitors and assessment

Company assessment

Broad incumbents

  • Elanco Animal Health: Major animal health pharma player in livestock and companion animals. Overlaps with Bimeda in parasiticides, BRD therapeutics, and equine segments, competing for distributor and veterinarian mindshare.
  • Merck Animal Health (MSD Animal Health): Global animal health division of Merck/MSD, with deep livestock and companion animal portfolios. Competes with Bimeda across vaccines, anti-infectives, and parasiticides worldwide.
  • Zoetis: Largest pure-play animal health company globally. Direct overlap with Bimeda across parasiticides, vaccines, anti-infectives, and equine products; Bimeda's bioequivalents target Zoetis's pioneer brands like GastroGard and Dectomax.
  • Boehringer Ingelheim Animal Health: Top-three global animal health player with broad livestock, companion, and equine portfolios. Bimeda's Eprimectin (bioequivalent to Eprinex) and other parasiticide products directly compete with Boehringer's pioneer franchises.

Direct peers

  • Vetoquinol: Independent French-headquartered animal health company focused on livestock and companion animals. Comparable to Bimeda in size, geographic footprint, and portfolio composition across parasiticides and specialty therapeutics.
  • Virbac: Independent global animal health company specializing in livestock and companion animal pharmaceuticals. Closely comparable to Bimeda in size, distribution model, and product breadth; both target veterinarians and livestock producers with parasiticides, anti-infectives, and specialty products.
  • Norbrook Laboratories: Privately held UK/Irish-headquartered animal health manufacturer of generic veterinary pharmaceuticals. Closely comparable to Bimeda in manufacturing footprint, bioequivalent focus, and livestock/companion product mix.
  • Ceva Santé Animale: Privately held global animal health company with strong livestock, poultry, and companion portfolios. Highly comparable to Bimeda in scale, ownership structure (private), and focus on multi-species veterinary pharmaceuticals.
  • Phibro Animal Health: Global animal health and nutrition company serving livestock and companion markets. Comparable to Bimeda in targeting livestock producers with parasiticides, anti-infectives, and nutritional products.

Emerging players

  • Dechra Pharmaceuticals: Specialty animal health pharma company with strength in companion animal endocrinology, dermatology, and equine. Bimeda's equine portfolio (Gastrobim, Polyglycan) overlaps with Dechra's specialty veterinary segment.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Bimeda social profiles

Digital presence

Bimeda compliance and trust

Trust signal

Compliance10 records

Bimeda financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bimeda leadership team

Management profile

Number of profiles

Profiles3 records

Bimeda subsidiaries and ownership

Company hierarchy

Subsidiaries12 records

Bimeda funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bimeda M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bimeda

What does Bimeda do?

Bimeda is a global manufacturer, marketer, and distributor of veterinary pharmaceuticals and animal health products. Its portfolio spans ecto- and endo-parasiticides, water soluble antimicrobials, injectables, nutritional products, vaccines, and trace element boluses serving livestock (cattle, swine, poultry), equine, and companion animal markets. Products are FDA-approved bioequivalents to pioneer brands, delivered through authorized distributors, veterinary clinics, and retail partners.

Is Bimeda a public or private company?

Bimeda is a private company. It is classified as unknown and is currently operating.

When was Bimeda founded?

Bimeda was founded in 1960. It employs 51 to 100 people.

Where is Bimeda based?

Bimeda is headquartered in Le Sueur, United States, in the North America region.

How does Bimeda make money?

One revenue line is on record: animal health product sales.

Who are Bimeda's main competitors?

Broad incumbents on record are Elanco Animal Health, Merck Animal Health (MSD Animal Health), Zoetis and Boehringer Ingelheim Animal Health. Direct peers are Vetoquinol, Virbac, Norbrook Laboratories, Ceva Santé Animale and Phibro Animal Health. Dechra Pharmaceuticals is listed as an emerging player.

Does Bimeda have an API?

No public API is recorded for Bimeda.

What industry is Bimeda in?

Bimeda's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAM, Generic & Private-Label Veterinary Pharmaceuticals, with a secondary code of HLAMAEAB, Livestock & Production Animal Therapeutics (Rx). Its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales